SCHEMBL97603

SCHEMBL97603

C[CH]c1ccc(OC)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.65
ALDH1A1 P00352 3/20 0.65
CYP3A4 P08684 2/20 0.65
LMNA P02545 2/20 0.65
TP53 P04637 1/20 0.65
TSHR P16473 1/20 0.65
CA12 O43570 1/20 0.61
CA1 P00915 1/20 0.61
CA2 P00918 1/20 0.61
CA7 P43166 1/20 0.61
CA9 Q16790 1/20 0.61
CA14 Q9ULX7 1/20 0.61
CYP2A6 P11509 1/20 0.61
TRPA1 O75762 1/20 0.56
RELA Q04206 1/20 0.56
CYP1A2 P05177 3/20 0.54
CYP1A1 P04798 3/20 0.54
CYP1B1 Q16678 3/20 0.54
ESR1 P03372 2/20 0.54
PTGS2 P35354 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4419860 0.93 ALDH1A1 (0.58) KDM4EALDH1A1CYP3A4LMNATP53
SCHEMBL631998 0.80 RELA (0.81) KDM4EALDH1A1CYP3A4LMNATP53
SCHEMBL27883 0.80 CA12 (0.65) KDM4EALDH1A1CYP3A4LMNATP53
SCHEMBL699457 0.80 RELA (0.81) KDM4EALDH1A1CYP3A4LMNATP53
SCHEMBL699458 0.80 RELA (0.81) KDM4EALDH1A1CYP3A4LMNATP53
SCHEMBL4881152 0.80 RELA (0.81) KDM4EALDH1A1CYP3A4LMNATP53
SCHEMBL13790336 0.80 RELA (0.81) KDM4EALDH1A1CYP3A4LMNATP53
SCHEMBL14950253 0.80 RELA (0.81) KDM4EALDH1A1CYP3A4LMNATP53
Anethole SCHEMBL57011 0.79 KDM4E (1.00) KDM4EALDH1A1CYP3A4LMNATP53
Anethole SCHEMBL48599 0.79 KDM4E (1.00) KDM4EALDH1A1CYP3A4LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1297 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024052356-A1 INHIBITORS OF THE CERAMIDE METABOLIC PATHWAY FOR OVERCOMING IMMUNOTHERAPY RESISTANCE IN CANCER Institut National de la Santé et de la Recherche Médicale (FR) 2024-03-14 WO claimed
EP-4273135-A1 PLASMIN INHIBITOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Scinnohub Pharmaceutical Co., Ltd (CN) 2023-11-08 EP claimed
CN-116710440-A Plasmin inhibitor, preparation method and application thereof 赛诺哈勃药业(成都)有限公司 2023-09-05 CN claimed
CN-116143631-A Pd/SnO 2 Method for preparing nitrogen-containing aromatic compound by catalyzing lignin 中国科学院大连化学物理研究所 2023-05-23 CN claimed
CN-116143638-A Method for preparing nitrogen-containing aromatic compound by catalyzing lignin through Fe-terpyridine 中国科学院大连化学物理研究所 2023-05-23 CN claimed
CN-116120271-A Genipin derivative and preparation method and application thereof 广东工业大学 2023-05-16 CN claimed
EP-3424913-B1 2,3-EPOXY SUCCINYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND USES THEREOF INST PHARMACOLOGY & TOXICOLOGY ACADEMY MILITARY MEDICAL SCIENCES PLA CHINA (CN) 2023-04-05 EP claimed
CN-115353506-A 3-substituted phenanthridine compound, preparation method and application thereof, and pharmaceutical composition 苏州施安鼎泰生物医药技术有限公司 2022-11-18 CN claimed
WO-2022117389-A1 METHOD FOR PRODUCING A TERMINAL-FUNCTIONAL POLYMER BASF SE (DE) 2022-06-09 WO claimed
CN-110183440-B Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2022-04-22 CN claimed
EP-0543780-A2 Novel aminoalkanephosphinic acids and their salts CIBA-GEIGY AG (CH) 1993-05-26 EP claimed
EP-0515514-A4 2-ARALKOXY AND 2-ALKOXY ADENOSINE DERIVATIVES AS CORONARY VASODILATORS AND ANTIHYPERTENSIVE AGENTS 1993-01-13 EP claimed
EP-0515514-A1 2-ARALKOXY AND 2-ALKOXY ADENOSINE DERIVATIVES AS CORONARY VASODILATORS AND ANTIHYPERTENSIVE AGENTS WHITBY RESEARCH, Inc. (US) 1992-12-02 EP claimed
US-5140015-A Racemic mixture for inducing an adenosine response in humans and animals WHITBY RESEARCH, INC. (US) 1992-08-18 US claimed
WO-1991013082-A1 2-ARALKOXY AND 2-ALKOXY ADENOSINE DERIVATIVES AS CORONARY VASODILATORS AND ANTIHYPERTENSIVE AGENTS WHITBY RESEARCH, INC. (US) 1991-09-05 WO claimed
EP-0343307-A1 4-Piperidinealkanamine derivatives FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (ES) 1989-11-29 EP claimed
EP-0161841-B1 2-(N-SUBSTITUTEGUANIDINO)-4-HETERO-ARYLTHIAZOLE ANTIULCER AGENTS PFIZER INC. (US) 1989-07-19 EP claimed
US-4566996-A Process for preparing azetidinone derivatives Otsuke Kagaku Yakuhin Kabushiki Kaisha (JP) 1986-01-28 US claimed
US-4560690-A ANTISECRETORY AGENTS, HISTAMINE H2-ANTAGONISTS PFIZER INC. (US) 1985-12-24 US claimed
EP-0161841-A1 2-(N-substituteguanidino)-4-hetero-arylthiazole antiulcer agents PFIZER INC. (US) 1985-11-21 EP claimed